ResearchEvolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma
ResearchImpact of Socioeconomic Determinants of Health on Delays to Care in Gastric Cancer: A National Cancer Database Analysis
ResearchReal-World Analysis of Irinotecan With or Without Fluorouracil in the Second-Line Treatment of Metastatic Colorectal Cancer
ResearchPhase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer
ResearchA First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors
ResearchImmune Landscape of Epstein-Barr Virus-Associated Gastric Cancer: Analysis From a Western Academic Institution
ResearchEffect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center
ResearchState-of-the-Art Advancements in Gastroesophageal Cancer Treatment: Harnessing Biomarkers for Precision Care
ResearchZolbetuximab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancers: A Plain Language Summary
ResearchA Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
ResearchRisk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer
Sep 30, 2024Journal ArticleThe Role of Metastasectomy in Patients with Liver-Only Metastases from Gastric Adenocarcinoma.Written by 1 Roon author & 10 others Via Annals of Surgical Oncology
ResearchMore May Not Be Better: Comparison of Oncologic Outcomes Following Induction Chemotherapy Plus Chemoradiation and Chemoradiation Alone for Esophageal Adenocarcinoma
ResearchEsophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology